Document is current
Any future updates will be listed below
-
Authors
Bentegeac, Raphaël
Achour, Djamal
Grare, Céline
Muntaner, Manon
Gauthier, Victoria
Amouyel, Philippe
Matran, Regis
Zerimech, Farid
Lo Guidice, Jean-Marc
Dauchet, Luc
-
Funding
Funding for this research was provided by:
Centre Hospitalier Universitaire de Lille
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 19 March 2025
First Online: 12 April 2025
Declarations
:
: The authors declare no competing interests.
: In compliance with the French legislation on biomedical research, the study protocol was approved by the local investigational review board (CPP Nord Ouest IV, Lille, France; reference: 2010-A00065-34; ClinicalTrials.gov identifier: NCT02490553). All the participants provided their written, informed consent to participation in the ELISABET study. This consent included the fact their blood would be added to a biobank, that new biomarkers might be measured subsequently and that their relation to air pollution would be studied. Our management of personal data followed applicable GDPR rules, including the removal of all patient data on refusal to stay in the ELISABET study. This led to approximately 100 patients being removed from our database.
